+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes



Prevalence of endocrine diseases in morbidly obese patients scheduled for bariatric surgery: beyond diabetes



Obesity Surgery 21(1): 54-60



Bariatric surgery allows stable body weight reduction in morbidly obese patients. In presurgical evaluation, obesity-related co-morbidities must be considered, and a multidisciplinary approach is recommended. Precise guidelines concerning the endocrinological evaluation to be performed before surgery are not available. The aim of this study was to evaluate the prevalence of common endocrine diseases in a series of obese patients scheduled for bariatric surgery. We examined 783 consecutive obese subjects (174 males and 609 females) aged 18-65 years, who turned to the obesity centre of our department from January 2004 to December 2007 for evaluation before bariatric surgery. Thyroid, parathyroid, adrenal and pituitary function was evaluated by measurement of serum hormones. Specific imaging or supplementary diagnostic tests were performed when indicated. The overall prevalence of endocrine diseases, not including type 2 diabetes mellitus, was 47.4%. The prevalence of primary hypothyroidism was 18.1%; pituitary disease was observed in 1.9%, Cushing syndrome in 0.8%, while other diseases were found in less than 1% of subjects. Remarkably, the prevalence of newly diagnosed endocrine disorders was 16.3%. A careful endocrinological evaluation of obese subjects scheduled for bariatric surgery may reveal undiagnosed dysfunctions that require specific therapy and/or contraindicate the surgical treatment in a substantial proportion of patients. These results may help to define the extent of the endocrinological screening to be performed in obese patients undergoing bariatric surgery.

(PDF emailed within 0-6 h: $19.90)

Accession: 055157525

Download citation: RISBibTeXText

PMID: 20953730

DOI: 10.1007/s11695-010-0297-6


Related references

Prevalence of endocrine disorders in morbidly obese patients and the effects of bariatric surgery on endocrine and metabolic parameters. Obesity Surgery 22(1): 62-69, 2012

Preventive effect of bariatric surgery on type 2 diabetes onset in morbidly obese inpatients: a national French survey between 2008 and 2016 on 328,509 morbidly obese patients. Surgery for Obesity and Related Diseases 2019, 2019

PL-103 Prevalence of psychiatric disease among morbidly obese patients undergoing bariatric surgery: Results from the michigan bariatric surgery collaborative. Surgery for Obesity and Related Diseases 7(3): 339-340, 2011

Post-surgery adherence to scheduled visits and compliance, more than personality disorders, predict outcome of bariatric restrictive surgery in morbidly obese patients. Obesity Surgery 17(11): 1492-1497, 2008

Prevalence of undiagnosed and inadequately treated type 2 diabetes mellitus, hypertension, and dyslipidemia in morbidly obese patients who present for bariatric surgery. Obesity Surgery 24(6): 927-935, 2015

Bariatric surgery significantly decreases the prevalence of type 2 diabetes mellitus and pre-diabetes among morbidly obese multiethnic adults: long-term results. Journal of the American College of Surgeons 212(4): 505-11; Discussion 512-3, 2011

Prevalence of defaecatory disorders in morbidly obese patients before and after bariatric surgery. Journal of Gastrointestinal Surgery 16(1): 62-6; Discussion 66-7, 2012

Prevalence and associated factors of obstructive sleep apnea in morbidly obese patients undergoing bariatric surgery. Sleep and Breathing 22(1): 251-256, 2017

Cost-Effectiveness Evaluation of Bariatric Surgery for Morbidly Obese with Diabetes Patients in Thailand. Journal of Obesity 2019: 5383478, 2019

Bariatric surgery improves the metabolic profile of morbidly obese patients with type 1 diabetes. Diabetes Care 37(3): E51-E52, 2015

Enhanced Recovery after Bariatric Surgery in the Severely Obese, Morbidly Obese, Super-Morbidly Obese and Super-Super Morbidly Obese Using Evidence-Based Clinical Pathways: a Comparative Study. Obesity Surgery 27(3): 560-568, 2016

Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery. Obesity Surgery 16(2): 183-188, 2006

Weighing the Clinical Benefits and Economic Impact of Bariatric Surgery in Morbidly Obese Patients with Diabetes. Canadian Journal of Diabetes 35(2): 89-98, 2011

Non-alcoholic Fatty Liver Disease in Morbidly Obese Individuals Undergoing Bariatric Surgery: Prevalence and Effect of the Pre-Bariatric Very Low Calorie Diet. Obesity Surgery 28(4): 1109-1116, 2017

Increased Prevalence of Irritable Bowel Syndrome in a Cohort of French Morbidly Obese Patients Candidate for Bariatric Surgery. Obesity Surgery 26(7): 1525-1530, 2017